# Independent content review — v0.15

**Result: PASS.** No unresolved actionable content or numerical finding remains in the frozen draft.

- Reviewed draft: `manuscript/DRAFT_v0_15.md`
- SHA256: `eb8a813bb328700a03f186033c4ff102ac0093f00b9a33425c936f71ef021cf3`
- Review date: 5 November 2026
- Reviewer: `/root/venue_and_story_audit`
- Author confirmed this hash as stable before the final check.

## Actionable findings and resolution

One minor precision issue was reported during review: Section 5.2's residual TC–HDL range described constructor means without naming the aggregation level. The author clarified it to “Across constructors, mean adjusted residual TC–HDL correlations ranged from 0.10828 to 0.14134 versus 0.51207.” The frozen draft contains that correction. No other content correction is requested.

## Numerical and display checks

| Check | Independent result |
|---|---|
| Old numerical tables | All **60 numerical data rows** from v14's six numerical result tables occur verbatim in v15 supplementary Tables S1–S6. The six study-design rows were rewritten, retaining their counts and information conditions. |
| Fig. 2 | **216 seed coefficients, 72 means, six panels** bind exactly to Q1 aggregates. There are 24 laws and 72 distinct final tables. Explicit caption adjustment sets match the frozen endpoints. |
| Fig. 3 | **54 seed estimates, 18 means, six panels** bind exactly to Q5 aggregates. Caption, renderer and inspected PNG all place HbA1c in **a/c/e on the left** and HDL/TC/residual correlation in **b/d/f on the right**. |
| Fig. 4 | **90 seed statistics, 30 means, five panels** bind to Q2 aggregates. Initial/final retained outputs are displayed once; all stored revision deltas are zero. |
| Fig. S3 | **36 dispersion values, 12 means, four panels** bind to Q5 aggregates. Population-form HbA1c SD, residual RMS and sample lipid SD retain their different definitions. |
| Aggregate arithmetic | JSON-pointer checks, independently calculated means and minima/maxima pass for **396 displayed seed values and 132 means**. Four source hashes match. All 12 redrawn SVG/PNG/PDF output hashes match the bindings. |
| Reused figures | All 12 files representing Fig. 1 and Figs. S1/S2/S4 are byte-identical to the v14 originals and match their reuse hashes. |
| Local references | All 32 local Markdown destinations resolve. |

The manuscript's primary numerical claims agree with the frozen records:

- **Q1:** Five of six Agent mean absolute-discrepancy contrasts decrease. CHNS BMI increases from 0.020380 to 0.031557; glucose decreases from 0.134019 to 0.024079. All six displayed E1–E0 differences use unrounded source values. The negative CHNS age constructor mean remains disclosed. The two favorable statistical-comparator results also check out: its E1 discrepancy is below every corresponding Agent for CHNS glucose and ENSANUT glucose-adjusted BMI.
- **Q5:** Six laws, 18 final tables, 24 physical attempts and 54,000 final fictional rows; all 54 primary point signs agree with the cached sample point signs. The complete aggregate has 513 outputs, 324 matched references and 189 generated-only diagnostics. All **72 numerical cells** representing reference/mean/min/max in Table S5 match the frozen summaries at the printed six-decimal precision. Effect, lipid-dependence and dispersion discrepancies remain prominent.
- **Q2:** Six authors and 18 distinct delivery tables are consistent with 42 physical executions and 24 distinct tables including trials. Retained initial/final deliveries are not counted as separate evidence.
- **Q4:** Four authors, twelve final tables, all 36 primary point directions and all 366 aggregate output entries are retained.
- **HRS:** The cited Agent mean −0.044635 agrees with −0.04463527866460568 in the frozen summary, against the supplied −0.046837. The 11,509 subjects × four visits, six valid tables and three invalid initial comparator attempts remain disclosed.
- **Evidence use:** The inventory yields eight original studies, 22 author–paper uses, seven query credits and one download. Independent enumeration of all six frozen feedback files confirms **132/132 checks marked `not_computable`**. Every Q5 author retained its initial law.
- **Worked mathematics:** The projected coefficients agree with the full-precision residual SDs in the existing source/assumptions supplement; the main text displays rounded SD inputs. The Spearman-to-Gaussian conversion gives 0.4567017402, appropriately shown as 0.457. The frozen analytical sensitivity contains +0.0342216678 and −0.0109457823 at correlations 0.10 and 0.40, and verifies the unchanged secondary projection.

## Scientific interpretation checks

The final draft distinguishes **sample-reference uncertainty** from generated sampling variability. CHNS community-cluster CR1-t intervals, ENSANUT empirical cluster-resampling stability bands and lipid HC3 assumption-conditional sensitivity intervals are not conflated. The TC reference interval crosses zero; no residual-correlation interval is supplied. Lipid-SD reference intervals remain unavailable. Seed ranges are explicitly conditional on frozen laws, not model/evidence uncertainty or equivalence thresholds.

The draft retains project-level reference exposure, fresh-context limitations, shared model services/sources, and the supplied-information roles of Q2/Q3. It describes direction matching as agreement with cached sample point estimates, not independent clinical confirmation. The analytical sensitivity is explicitly not a causal intervention or additional cohort experiment.

No unsupported first-priority, new-distribution, universal accuracy, component advantage, feedback-improvement or human-time-saving claim was found. G-Sim, LLMSynthor, SynthCraft and SPADA retain their neighboring roles. The positive contribution remains scientific evidence qualification and numerical use within executable joint-law construction. Quantitative cohort replacement, calibrated design/power use, broad transport and arbitrary-request autonomy remain unestablished.

## Scope and limits of PASS

This review independently checks manuscript statements, preserved numerical tables, display mappings and arithmetic **against frozen aggregate artifacts**. It does not rerun generators, access individual real/generated rows, refit clinical data, validate source studies, or establish biological transport. The four redrawn PNGs were inspected for content and panel mapping; final assembled-PDF layout and venue compliance are separate checks.

The companion JSON records the exact draft hash, source hashes, check results and resolved finding. Any later draft edit requires rebinding this review. PASS indicates content consistency for this scientific reading copy, not submission readiness or stronger clinical validity.
